eli lilly gip/glp-1 touts new weight-loss shot, says stronger than old GLP-1s Novo Nordisk, Eli Lilly make

The risk-benefit calculation for semaglutide remains favorable for most patients with obesity or type 2 diabetes, conditions that carry their own serious long-term health risks

The monthly price was within my budget, and I knew the lead nurse practitioner so felt comfortable with the process and trusted her expertise

Correct stapling technique in laparoscopic sleeve gastrectomy: are we increasing the bleeding

In recent years, we have witnessed a paradigm shift in cardiometabolic medicine: The SELECT trial demonstrated that GLP-1 receptor agonists reduce cardiovascular events even in patients without diabetes

Fiber supplements can help if youre falling short through food alone, but Miranda recommends starting with whole foods first